TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087 (Q73250646)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

1 reference

(2R)-N'-[(2R,3R)-3-hydroxy-1-[[(2S,3R)-3-hydroxy-1-[[(2R)-1-[(2S)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-2-methylpropanediamide

1 reference

inferred from

reverse claim

(2S)-N'-[(2S,3R)-3-hydroxy-1-[[(2S,3R)-3-hydroxy-1-[[(2R)-1-[(2R)-2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-2-methylpropanediamide

1 reference

inferred from

reverse claim

(2S)-N'-[(2S)-3-hydroxy-1-[[(2S)-3-hydroxy-1-[[1-[2-(hydroxymethyl)oxiran-2-yl]-4-methyl-1-oxopentan-2-yl]amino]-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-2-methylpropanediamide

1 reference

Y Koguchi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Nishio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Suzuki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Takahashi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Ohnuki

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Komatsubara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 November 2019

publication date

2000

3 references

16 September 2022

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/53/9/53_9_967/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.967?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

967-972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.53.967?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities.

2 references

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.53.105

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. II. Physico-chemical properties and structure determination

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

Pituitary multicatalytic proteinase complex. Specificity of components and aspects of proteolytic activity

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

TMC-86A, B and TMC-96, new proteasome inhibitors from Streptomyces sp. TC 1084 and Saccharothrix sp. TC 1094. I. Taxonomy, fermentation, isolation, and biological activities.

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.52.1069

Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

c-Fos degradation by the proteasome. An early, Bcl-2-regulated step in apoptosis

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

Structures of TMC-95A-D: novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.53.967

Identifiers

DOI

10.7164/ANTIBIOTICS.53.967

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11099231%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference